Christopher R. Cline
Chief Financial Officer at Travere Therapeutics · 14 reported transactions in 1 company · latest trade Sep 15, 2026
Their trades
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Sep 15, 2026 | Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days. | ||
Sold | Feb 4, 2026 | Feb 4, 2026 close $31.68 → Oct 29, 2026 close $50.57. S&P 500 +12.1% over the same days. | ||
Sold | Feb 4, 2026 | Feb 4, 2026 close $31.68 → Oct 29, 2026 close $50.57. S&P 500 +12.1% over the same days. | ||
Sold | Feb 3, 2026 | Feb 3, 2026 close $32.84 → Oct 29, 2026 close $50.57. S&P 500 +11.6% over the same days. | ||
Sold | Dec 1, 2025 | Dec 1, 2025 close $35.19 → Oct 29, 2026 close $50.57. S&P 500 +13.1% over the same days. |
$26.1K
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$121K
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$1.3M
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$1.7M
Sep 15, 2026 close $62.51 → Oct 29, 2026 close $50.57. S&P 500 +1.6% over the same days.
$3.6K
Feb 4, 2026 close $31.68 → Oct 29, 2026 close $50.57. S&P 500 +12.1% over the same days.
$52.5K
Feb 4, 2026 close $31.68 → Oct 29, 2026 close $50.57. S&P 500 +12.1% over the same days.
$232.6K
Feb 3, 2026 close $32.84 → Oct 29, 2026 close $50.57. S&P 500 +11.6% over the same days.
$700.2K
Dec 1, 2025 close $35.19 → Oct 29, 2026 close $50.57. S&P 500 +13.1% over the same days.